![Brady Beauchamp](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Brady Beauchamp had held the position of COO at Debut Biotechnology, Inc. from 2019 to 2020.
He is also the founder of Debut Biotechnology, Inc. which was founded in 2019.
Eerdere bekende functies van Brady Beauchamp
Bedrijven | Functie | Einde |
---|---|---|
Debut Biotechnology, Inc.
![]() Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Oprichter | 31-10-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Debut Biotechnology, Inc.
![]() Debut Biotechnology, Inc. BiotechnologyHealth Technology Debut Biotechnology, Inc. engages in the manufacture of high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. The firm's cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals. The company was founded by Joshua Britton, Brady Beauchamp, and Gregory Weiss and is headquartered in San Diego, CA. | Health Technology |